Val158Met Polymorphism in the Catechol-O-Methyltransferase (COMT) Gene Is Not Associated with Tardive Dyskinesia in Schizophrenia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuropsychobiology

• Publication date

  2008-04-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000123118PMID 18424907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No evidence for an association between G protein β3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia

  2007cited by this paper
• No Association between Dopamine D4 Receptor Gene –521 C/T Polymorphism and Tardive Dyskinesia in Schizophrenia

  2007cited by this paper
• Pharmacogenetic Studies Investigating the Adverse Effects of Antipsychotics

  2007cited by this paper
• Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms

  2006cited by this paper
• Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

  2005cited by this paper
• Negative association between Catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia

  2005cited by this paper
• The 10-Minute Oral Presentation: What Should I Focus on?

  2005cited by this paper
• Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia

  2004cited by this paper
• COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor

  2003cited by this paper
• Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene.

  2003cited by this paper
• Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype

  2001cited by this paper
• Association Analysis of a Functional Catechol-O-Methyltransferase Gene Polymorphism in Schizophrenic Patients in Taiwan

  2001cited by this paper
• Molecular heterosis: a review.

  2000influential reference
• The Current Status of Tardive Dyskinesia

  2000cited by this paper
• Familial occurrence of tardive dyskinesia.

  1998cited by this paper
• Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics.

  1998cited by this paper
• Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia.

  1997cited by this paper
• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

  1996cited by this paper
• Pharmacological Options for the Management of Dyskinesias

  1996cited by this paper
• No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity.

  1996cited by this paper
• Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

  1995cited by this paper
• Possible genetic factors underlying the pathophysiology of tardive dyskinesia.

  1994cited by this paper
• Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.

  1988cited by this paper
• Tardive dyskinesia: prevalence, incidence, and risk factors.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Tardive dyskinesia: prevalence, incidence, and risk factors.

  1985cited by this paper
• Research diagnoses for tardive dyskinesia.

  1982cited by this paper
• Familial tardive dyskinesia.

  1981cited by this paper
• The pathophysiologic basis of tardive dyskinesia.

  1977cited by this paper

• Associations between Catechol-O-methyltransferase (COMT) polymorphisms and cognitive impairments, psychiatric symptoms and tardive dyskinesia in schizophrenia.

  2023cites this paper
• Genetic Variation as a Possible Explanation for the Heterogeneity of Pain in Tendinopathy: What can we learn from other pain syndromes?

  2021cites this paper
• The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects

  2020cites this paper
• Association Study between Serotonin 1A Receptor Gene rs6295 Polymorphism and Tardive Dyskinesia in Patients with Schizophrenia

  2020cites this paper
• The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk

  2016cites this paper
• Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia

  2014cites this paper
• There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients

  2013cites this paper
• A genetic dissection of antipsychotic induced movement disorders.

  2013cites this paper
• No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients

  2012cites this paper
• Association Study between Tryptophan Hydroxylase 2 Gene -703G/T Polymorphism and Tardive Dyskinesia

  2012cites this paper
• Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction

  2011cites this paper
• No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients

  2011cites this paper
• Genetics of tardive dyskinesia.

  2011cites this paper
• COMT and age at onset in mood disorders: a replication and extension study.

  2011cites this paper
• The catechol-O-methyl-transferase gene in tardive dyskinesia

  2010cites this paper
• No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia

  2009cites this paper
• Association study between glutathione S‐transferase GST‐M1, GST‐T1, and GST‐P1 polymorphisms and tardive dyskinesia

  2009cites this paper
• Biological psychiatry in Korea

  2008cites this paper
• Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.

  2008cites this paper